The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Open accessAbstract
Desperately Seeking Glucose: Mutations in oncogenes and tumor suppressor genes allow cancer cells to outgrow their neighboring healthy cells. What microenvironmental conditions provide a selective growth advantage to these cells? Yun et al. (p. 1555 , published online 6 August) identify low glucose availability as a microenvironmental factor driving the acquisition of KRAS oncogenic mutations that allow cancer cells to survive and grow. In genetically matched colorectal cancer cells that differed only in the mutational status of the KRAS oncogene, mutant cells selectively overexpressed glucose transporter-1 and exhibited enhanced glucose uptake and glycolysis. When cells with wild-type KRAS were placed in a low-glucose environment, very few cells survived but most of the survivors expressed high levels of glucose transporter-1, and a small percentage of the survivors had acquired new KRAS mutations. Thus, glucose deprivation may help to drive the acquisition of cell growth–promoting oncogenic mutations during tumor development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Gene expression and metabolic flux analyses have shown that it upregulates the expression of the GLUT1 glucose transporter to promote glucose uptake by cells, as well as inducing expression of hexokinase 1 and 2 (HK1 and HK2) rate-limiting enzymes of glycolysis, to increase glycolytic activity27–30 (Fig. 2a).”
From The metabolic landscape of RAS-driven cancers from biology to therapy (2021) · cites this paper as [30]
In the citing paper
“Oncogenic KRAS or BRAF mutations contribute to the Warburg effect, in part by upregulating GLUT1 (REF46).”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [46]
In the citing paper
“Direct data concerning dose-response characteristics of cancers to glucose are sparse, but it is relevant that most cancers have highly effective upregulated, insulin-independent glucose uptake mechanisms (67) and therefore may not derive a further growth advantage from hyperglycemia.”
From Diabetes and Cancer (2010) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Self-citationras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,346
Self-citationTargeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc969 · Cited by 3,354
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
Flagged first, then by citations
1 of the 42 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Bos J. L., Cancer Res. 49, 4682 (1989).2547513
- Airley R., et al.., Clin. Cancer Res. 7, 928 (2001).11309343
- Yasuda S., et al.., J. Nucl. Med. 42, 989 (2001).11438616
- Delbeke D., et al.., J. Nucl. Med. 38, 1196 (1997).9255148
Cited by
Sorted by citations
Items 201–300 of 910
Zhao, J., Jin, D., Huang, M., Ji, J., Xu, X., Wang, F., Zhou, L., Bao, B., Jiang, F., Xu, W., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1416472 · Cited by 84
Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1
Hamilton, K. E., Rekman, J. F., Gunnink, L. K., Busscher, B. M., Scott, J. L., Tidball, A. M., Stehouwer, N. R., Johnecheck, G. N., Looyenga, B. D., & Louters, L. L. (2018) · Biochimie · doi:10.1016/j.biochi.2018.05.012 · Cited by 84
A smart hydrogel system for visual detection of glucose
Wu, M., Zhang, Y., Liu, Q., Huang, H., Wang, X., Shi, Z., Li, Y., Liu, S., Xue, L., & Lei, Y. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111547 · Cited by 83
Dynamics of targeted cancer therapy
Božić, I., Allen, B., & Nowak, M. A. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.006 · Cited by 86
Interactions between epigenetics and metabolism in cancers
Yun, J., Johnson, J. L., Hanigan, C. L., & Locasale, J. W. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00163 · Cited by 82
Self-citationMACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect
Li, L., Huang, H., Liao, W., Ma, H., Liu, J., Wang, L., Huang, N., Liao, Y., & Liao, W. (2014) · Oncogene · doi:10.1038/onc.2014.204 · Cited by 85
Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation
He, Q., Minn, I., Wang, Q., Xu, P. H., Head, S. A., Datan, E., Yu, B., Pomper, M. G., & Liu, J. O. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201606121 · Cited by 82
The Progress and Development of GLUT1 Inhibitors Targeting Cancer Energy Metabolism
Meng, Y., Xu, X. J., Luan, H., Li, L., Dai, W., Li, Z., & Bian, J. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0052 · Cited by 85
Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells
Brunelli, L., Caiola, E., Marabese, M., Broggini, M., & Pastorelli, R. (2014) · Oncotarget · doi:10.18632/oncotarget.1958 · Cited by 82
The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming
Eng, C. H., & Abraham, R. T. (2011) · Oncogene · doi:10.1038/onc.2011.220 · Cited by 83
Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer
Sawayama, H., Ogata, Y., Ishimoto, T., Mima, K., Hiyoshi, Y., Iwatsuki, M., Baba, Y., Miyamoto, Y., Yoshida, N., & Baba, H. (2019) · Cancer Science · doi:10.1111/cas.13995 · Cited by 82
Yang, Y., Chong, Y., Chen, M., Dai, W., Zhou, X., Ji, Y., Qiu, G., & Du, X. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02825-2 · Cited by 82
High-Dose Vitamin C for Cancer Therapy
Mussa, A., Idris, R. A. M., Ahmed, N., Ahmad, S., Murtadha, A. H., Din, T. A. D. A. T., Yean, C. Y., Rahman, W. F. W. A., Lazim, N. M., Uskoković, V., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15060711 · Cited by 85
Bhattacharya, B., Low, S. H. H., Soh, C. K., Mustapa, N. K., Beloueche‐Babari, M., Koh, K. X., Loh, J. Y., & Soong, R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12668 · Cited by 81
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations
Hammond, D. E., Mageean, C. J., Rusilowicz, E. V., Wickenden, J. A., Clague, M. J., & Prior, I. A. (2015) · Journal of Proteome Research · doi:10.1021/pr501191a · Cited by 81
Metabolism and Its Sequelae in Cancer Evolution and Therapy
Gillies, R. J., & Gatenby, R. A. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000102 · Cited by 80
Bioluminescent-based imaging and quantification of glucose uptake in vivo
Maric, T., Mikhaylov, G., Khodakivskyi, P. V., Bazhin, A. A., Sinisi, R., Bonhoure, N., Yevtodiyenko, A., Jones, A. E., Muhunthan, V., Abdelhady, G., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0421-z · Cited by 80
Coffee, E. M., Faber, A. C., Roper, J., Sinnamon, M. J., Goel, G., Keung, L., Wang, W. V., Vecchione, L., de Vriendt, V., Weinstein, B., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2556 · Cited by 80
Li, X., Yin, G., Zhang, Y., Dai, D., Liu, J., Chen, P., Zhu, L., Ma, W., & Xu, W. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01062 · Cited by 79
Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer
Toda, K., Nishikawa, G., Iwamoto, M., Itatani, Y., Takahashi, R., Sakai, Y., & Kawada, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081632 · Cited by 77
Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
O’Sullivan, É., Keogh, A., Henderson, B., Finn, S. P., Gray, S. G., & Gately, K. A. (2023) · Cancers · doi:10.3390/cancers15061635 · Cited by 84
Exploiting tumor metabolism: challenges for clinical translation
Heiden, M. G. V. (2013) · Journal of Clinical Investigation · doi:10.1172/jci72391 · Cited by 79
Emerging technologies for hybridization based single nucleotide polymorphism detection
Knez, K., Spasić, D., Janssen, K. P. F., & Lammertyn, J. (2013) · The Analyst · doi:10.1039/c3an01436c · Cited by 76
Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9
Yu, B., Swatkoski, S., Holly, A. J., Lee, L. C., Giroux, V., Lee, C.-S., Hsu, D. J., Smith, J. L., Yuen, G., Yue, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415569112 · Cited by 76
lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1
Liu, X., & Gan, B. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1249545 · Cited by 77
González‐Menéndez, P., Hevia, D., Mayo, J. C., & Sainz, R. M. (2017) · International Journal of Cancer · doi:10.1002/ijc.31165 · Cited by 78
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures
Graham, N. A., Minasyan, A., Lomova, A., Cass, A. A., Balanis, N. G., Friedman, M., Chan, S. T., Zhao, S. R., Delgado, A., Go, J. L., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20167159 · Cited by 78
Dowling, C. M., Hollinshead, K. E. R., Grande, A. D., Pritchard, J. R., Zhang, H., Dillon, E., Haley, K. E., Papadopoulos, E., Mehta, A. K., Bleach, R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abc4897 · Cited by 76
Targeting KRAS: from metabolic regulation to cancer treatment
Shi, Y., Zheng, H., Wang, T., Zhou, S., Zhao, S., Li, M., & Cao, B. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02216-3 · Cited by 81
Self-citationA glycolytic metabolite bypasses “two-hit” tumor suppression by BRCA2
Kong, L. R., Gupta, K., Wu, A., Perera, D., Iványi-Nagy, R., Ahmed, S. M., Tan, T. Z., Tan, S. L.-W., Fuddin, A., Sundaramoorthy, E., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.006 · Cited by 74
Verduzco, D., Lloyd, M. C., Xu, L., Ibrahim‐Hashim, A., Balagurunathan, Y., Gatenby, R. A., & Gillies, R. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120958 · Cited by 75
Azevedo‐Silva, J., Queirós, O., Baltazar, F., Ułaszewski, S., Goffeau, A., Ko, Y. H., Pedersen, P. L., Preto, A., & Casal, M. (2016) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-016-9670-z · Cited by 74
Understanding the Therapeutic Potential of Ascorbic Acid in the Battle to Overcome Cancer
Reang, J., Sharma, P. C., Thakur, V. K., & Majeed, J. (2021) · Biomolecules · doi:10.3390/biom11081130 · Cited by 73
Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma
Tian, P., Sun, F., Yang, J.-C., Cai, M.-H., Huai, M., Pan, J., Zhang, F., & Xu, L. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i19.2575 · Cited by 76
Wang, M.-D., Wu, H., Huang, S., Zhang, H., Qin, C., Zhao, L., Fu, G., Zhou, X., Wang, X., Tang, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6817 · Cited by 73
VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
Curtarello, M., Zulato, E., Nardo, G., Valtorta, S., Guzzo, G., Rossi, E. M. C., Esposito, G., Msaki, A., Pastò, A., Rasola, A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2037 · Cited by 75
Jonckheere, N., Vasseur, R., & SEUNINGEN, I. V. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.01.002 · Cited by 73
Macrophages in pancreatic cancer: An immunometabolic perspective
Yang, J. M., Li, Y., Sun, Z., & Zhan, H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.029 · Cited by 72
Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Merz, V., Gaule, M., Zecchetto, C., Cavaliere, A., Casalino, S., Pesoni, C., Contarelli, S., Sabbadini, F., Bertolini, M., Mangiameli, D., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.638360 · Cited by 74
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy
Xu, C., Liu, Y., Shen, S., Zhu, Y., & Wang, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.068 · Cited by 71
Carson, R., Çeltikçi, B., Fenning, C., Javadi, A., Crawford, N., Pérez–Carbonell, L., Lawler, M., Longley, D. B., Johnston, P. G., & Schaeybroeck, S. V. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2701 · Cited by 71
Regulation of 18F-FDG Accumulation in Colorectal Cancer Cells with Mutated KRAS
Iwamoto, M., Kawada, K., Nakamoto, Y., Itatani, Y., Inamoto, S., Toda, K., Kimura, H., Sasazuki, T., Shirasawa, S., Okuyama, H., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.142927 · Cited by 74
Rahman, A. M. A., Ryczko, M. C., Pawling, J., & Dennis, J. W. (2013) · ACS Chemical Biology · doi:10.1021/cb4004173 · Cited by 75
Attacking the supply wagons to starve cancer cells to death
Selwan, E. M., Finicle, B. T., Kim, S. M., & Edinger, A. L. (2016) · FEBS Letters · doi:10.1002/1873-3468.12121 · Cited by 73
Wang, Y., Yun, Y., Wu, B., Wen, L., Wen, M., Yang, H., Zhao, L., Liu, W., Huang, S., Wen, N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10103 · Cited by 73
Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies
Pantel, A. R., Ackerman, D., Lee, S., Mankoff, D. A., & Gade, T. P. F. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.199869 · Cited by 70
Computational Model Predicts the Effects of Targeting Cellular Metabolism in Pancreatic Cancer
Roy, M., & Finley, S. D. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00217 · Cited by 70
Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review
Pezzuto, A., D’Ascanio, M., Rícci, A., Pagliuca, A., & Carico, E. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13651 · Cited by 72
Metabolic reprogramming in colorectal cancer: regulatory networks and therapy
Zhang, J., Zou, S., & Fang, L. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00977-w · Cited by 73
The metabolic cooperation between cells in solid cancer tumors
Icard, P., Kafara, P., Steyaert, J., Schwartz, L. H., & Lincet, H. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.06.002 · Cited by 74
Molecular Biology and Evolution of Cancer: From Discovery to Action
Somarelli, J. A., Gardner, H. L., Cannataro, V. L., Gunady, E. F., Boddy, A. M., Johnson, N., Fisk, J. N., Gaffney, S. G., Chuang, J. H., Li, S., et al. (2019) · Molecular Biology and Evolution · doi:10.1093/molbev/msz242 · Cited by 69
Regulation of Aerobic Glycolysis by microRNAs in Cancer.
Singh, P. K., Mehla, K., Hollingsworth, M. A., & Johnson, K. R. (2011) · PubMed · Cited by 68
Neitzel, C., Demuth, P., Wittmann, S., & Fahrer, J. (2020) · Cancers · doi:10.3390/cancers12071731 · Cited by 70
Diabetes mellitus: influences on cancer risk
Szablewski, L. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2573 · Cited by 69
Zhao, H., Wu, S., Li, H., Duan, Q., Zhang, Z., Shen, Q., Wang, C., & Yin, T. (2019) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2019.07.005 · Cited by 67
Palorini, R., Rasmo, D. D., Gaviraghi, M., Danna, L. S., Signorile, A., Cirulli, C., Chiaradonna, F., Alberghina, L., & Papa, S. (2012) · Oncogene · doi:10.1038/onc.2012.50 · Cited by 68
Lewies, A., Wentzel, J. F., Miller, H. C., & Plessis, D. (2017) · Biochimie · doi:10.1016/j.biochi.2017.10.009 · Cited by 66
Identification of mutant K-Ras-dependent phenotypes using a panel of isogenic cell lines
Vartanian, S., Bentley, C., Brauer, M. J., Li, L., Shirasawa, S., Sasazuki, T., Kim, J.-S., Haverty, P., Stawiski, E., Modrusan, Z., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394130 · Cited by 65
Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
Liu, Y.-H., Hu, C., Hsu, Y.-S., & Lee, W. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05259-w · Cited by 74
Liu, J., van der Hoeven, R., Kattan, W. E., Chang, J. T., Montufar‐Solis, D., Chen, W., Wong, M., Zhou, Y., Lebrilla, C. B., & Hancock, J. F. (2023) · Nature Communications · doi:10.1038/s41467-023-36128-5 · Cited by 65
Regulation of UHRF 1 by micro RNA ‐9 modulates colorectal cancer cell proliferation and apoptosis
Zhu, M., Xu, Y., Ge, M., Gui, Z., & Yan, F. (2015) · Cancer Science · doi:10.1111/cas.12689 · Cited by 65
de Oliveira, A. T. T., Pinheiro, C. M., Longatto‐Filho, A., Brito, M. J., Martinho, O., Matos, D., Carvalho, A. L., Vazquez, V. D. L., Silva, T. B., Scapulatempo‐Neto, C., et al. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9408-5 · Cited by 65
Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis
Barger, J. F., & Plas, D. R. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0106 · Cited by 65
Moran, D. M., Trusk, P. B., Pry, K., Paz, K., Sidransky, D., & Bacus, S. S. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0649 · Cited by 64
Benton, G., DeGray, G., Kleinman, H. K., George, J., & Arnaoutova, I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123312 · Cited by 67
HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer
Burkhart, R. A., Pineda, D. M., Chand, S. N., Romeo, C., Londin, E. R., Karoly, E. D., Cozzitorto, J. A., Rigoutsos, I., Yeo, C. J., Brody, J. R., et al. (2013) · RNA Biology · doi:10.4161/rna.25274 · Cited by 64
Li, L., Gao, F., Ye, J., Chen, Z., Li, Q., Gao, W. Z., Ji, L., Zhang, R., & Tang, B. (2013) · Analytical Chemistry · doi:10.1021/ac4021227 · Cited by 64
Linking Metabolic Reprogramming, Plasticity and Tumor Progression
Shuvalov, O., Daks, A., Fedorova, O., Petukhov, A., & Barlev, N. (2021) · Cancers · doi:10.3390/cancers13040762 · Cited by 63
Overview of Cancer Metabolism and Signaling Transduction
Chae, H., & Hong, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010012 · Cited by 66
Glucose-independent Acetate Metabolism Promotes Melanoma Cell Survival and Tumor Growth
Lakhter, A. J., Hamilton, J., Konger, R. L., Brustovetsky, N., Broxmeyer, H. E., & Naidu, S. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712166 · Cited by 71
KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
Zhang, Z., Zhang, H., Liao, X., & Tsai, H. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147676 · Cited by 62
Marín‐Hernández, Á., López‐Ramírez, S. Y., Mazo‐Monsalvo, I. D., Gallardo‐Pérez, J. C., Rodríguez‐Enríquez, S., Moreno‐Sánchez, R., & Saavedra, E. (2014) · FEBS Journal · doi:10.1111/febs.12864 · Cited by 64
Tumor metabolism regulating chemosensitivity in ovarian cancer
Han, C. Y., Patten, D. A., Richardson, R. B., Harper, M., & Tsang, B. K. (2018) · Genes & Cancer · doi:10.18632/genesandcancer.176 · Cited by 62
Mutation–selection balance and compensatory mechanisms in tumour evolution
Persi, E., Wolf, Y. I., Horn, D., Ruppin, E., Demichelis, F., Gatenby, R. A., Gillies, R. J., & Koonin, E. V. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-00299-4 · Cited by 64
Baudy, A. R., Dogan, T., Flores-Mercado, J. E., Hoeflich, K. P., Su, F., van Bruggen, N., & Williams, S. (2012) · EJNMMI Research · doi:10.1186/2191-219x-2-22 · Cited by 61
Vitamin C Transporters and Their Implications in Carcinogenesis
Linowiecka, K., Foksiński, M., & Brożyna, A. A. (2020) · Nutrients · doi:10.3390/nu12123869 · Cited by 61
Enhanced triacylglycerol catabolism by carboxylesterase 1 promotes aggressive colorectal carcinoma
Capece, D., D’Andrea, D., Begalli, F., Goracci, L., Tornatore, L., Alexander, J. L., Veroli, A. D., Leow, S. C., Vaiyapuri, T. S., Ellis, J. K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci137845 · Cited by 60
Metabolic reprogramming of the premalignant colonic mucosa is an early event in carcinogenesis
Cruz, M. D., Ledbetter, S. E., Chowdhury, S., Tiwari, A. K., Momi, N., Wali, R. K., Bliss, C. M., Huang, C. S., Lichtenstein, D. R., Bhattacharya, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16129 · Cited by 61
Immunometabolism: new insights and lessons from antigen-directed cellular immune responses
Ramalho, R., Rao, M., Zhang, C., Agrati, C., Ippolito, G., Wang, F., Zumla, A. I., & Maeurer, M. J. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00798-w · Cited by 63
Zaanan, A., Okamoto, K., Kawakami, H., Khazaie, K., Huang, S., & Sinicrope, F. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.657833 · Cited by 59
Gatza, M. L., Kung, H., Blackwell, K., Dewhirst, M. W., Marks, J. R., & Chi, J. (2011) · Breast Cancer Research · doi:10.1186/bcr2899 · Cited by 59
From cancer metabolism to new biomarkers and drug targets
Chiaradonna, F., Moresco, R. M., Airoldi, C., Gaglio, D., Palorini, R., Nicotra, F., Messa, C., & Alberghina, L. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.07.006 · Cited by 61
The Effects of GLUT1 on the Survival of Head and Neck Squamous Cell Carcinoma
Li, S., Yang, X., Wang, P., & Ran, X. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000354466 · Cited by 59
A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma
Windon, A. L., Loaiza‐Bonilla, A., Jensen, C. E., Randall, M. P., Morrissette, J. J. D., & Shroff, S. G. (2018) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2017.10.14 · Cited by 61
Palorini, R., Simonetto, T., Cirulli, C., & Chiaradonna, F. (2013) · International Journal of Cell Biology · doi:10.1155/2013/243876 · Cited by 58
Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer
Kawada, K., Toda, K., Nakamoto, Y., Iwamoto, M., Hatano, E., Chen, F., Hasegawa, S., Togashi, K., Date, H., Üemoto, S., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.160614 · Cited by 58
Hübner, J., Marienfeld, S., Abbenhardt, C., Ulrich, C. M., Muenstedt, K., Micke, O., Mücke, R., & Löser, C. (2014) · PubMed · Cited by 58
Ren, X., Santhosh, S. M., Coppo, L., Ogata, F. T., Lu, J., & Holmgren, A. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.037 · Cited by 59
Mitochondrial-targeted nanoparticles: Delivery and therapeutic agents in cancer
Ganji, C., Muppala, V., Khan, M., Nagaraju, G. P., & Farran, B. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103469 · Cited by 57
Metabolism and epigenetics of pancreatic cancer stem cells
Lanfranca, M. P., Thompson, J. K., Bednar, F., Halbrook, C. J., Lyssiotis, C. A., Lévi, B., & Frankel, T. L. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.09.008 · Cited by 58
BRAFV600E-dependent Mcl-1 stabilization leads to everolimus resistance in colon cancer cells
He, K., Chen, D., Ruan, H., Li, X., Tong, J., Xu, X. M., Zhang, L., & Yu, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10277 · Cited by 56
Yu, H., Li, J., Peng, S., Liu, Q., Chen, D., He, Z., Xiang, J., & Wang, B. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217385 · Cited by 56
Hypoxia Induced Tumor Metabolic Switch Contributes to Pancreatic Cancer Aggressiveness
Vasseur, S., Tomasini, R., Tournaire, R., & Iovanna, J. (2010) · Cancers · doi:10.3390/cancers2042138 · Cited by 56
Rahman, A. M. A., Ryczko, M. C., Nakano, M., Pawling, J., Rodrigues, T., Johswich, A., Taniguchi, N., & Dennis, J. W. (2014) · Glycobiology · doi:10.1093/glycob/cwu105 · Cited by 55
Liang, Y., Ye, F., Luo, D., Long, L., Wang, Y., Jin, Y., Wang, L., Li, Y., Han, D., Chen, B., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02037-4 · Cited by 54
Jin, F., Zhou, S., Fan, J., & Yan, S. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2888 · Cited by 55
Self-citationFisher, K. W., Das, B., Kortum, R. L., Chaika, O. V., & Lewis, R. E. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05255-11 · Cited by 60
Mechanisms underlying18F-fluorodeoxyglucose accumulation in colorectal cancer
Kawada, K., Iwamoto, M., & Sakai, Y. (2016) · World Journal of Radiology · doi:10.4329/wjr.v8.i11.880 · Cited by 61
Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.
Schcolnik‐Cabrera, A., Chávez-Blanco, A. D., Domínguez-Gómez, G., & Dueñas‐González, A. (2017) · Europe PMC (PubMed Central) · Cited by 54
Hou, M., Su, H., Wu, Q., Sun, W., Zhang, P., Jiang, Y., Qian, K., & Zhang, C. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202212510 · Cited by 54
Metadata
- Authors
- Yun, J., Rago, C., Cheong, I., Pagliarini, R., Angenendt, P., Rajagopalan, H., Schmidt, K., Willson, J. K. V., Markowitz, S., Zhou, S., Diaz, L. A., Velculescu, V. E., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Papadopoulos, N.
- Affiliations
- Howard Hughes Medical Institute (US)
- The Ludwig Center for Cancer Genetics and Therapeutics and The Howard Hughes Medical Institute at the Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231, USA.
- Harold C. Simmons Comprehensive Cancer Center (US)
- Corresponding author
- Rajagopalan, Harith
- Vogelstein, Bert
- ORCID
- Venue
- Science
- Published
- 2009-09-18
- Volume
- 325
- Issue
- 5947
- Pages
- 1555-1559
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2820374
- OpenAlex
- W1970766774
- Cited by
- 914
- References
- 42
- Citations by year
- 2026: 21 · 2025: 39 · 2024: 43 · 2023: 47 · 2022: 48 · 2021: 60 · 2020: 70 · 2019: 75 · 2018: 61 · 2017: 60 · 2016: 63 · 2015: 51 · 2014: 87 · 2013: 48 · 2012: 61
- FWCI
- 15.77
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA43460, R37CA043460, P50CA062924, CA 62924)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- glucose deprivation, KRAS mutation, BRAF mutation, GLUT1, glucose transporter 1, colorectal cancer cell lines, tumor progression, glycolysis, glucose uptake, 3-bromopyruvate, transcriptome
- MeSH terms
- Animals, Glucose, Glycolysis, Humans, Mice, Nude, Mutation, Neoplasm Transplantation, Pyruvates, Genes, ras, Transplantation, Heterologous, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Gene Targeting, Lactic Acid, Oligonucleotide Array Sequence Analysis, Cell Line, Tumor, Proto-Oncogene Proteins B-raf, Cell Proliferation, Glucose Transporter Type 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
